Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana I Rojo

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Current Pharmaceutical Design|February 22, 2008
Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infectionsAntonio Cuadrado, Ana I Rojo
Redox Biology|January 21, 2017
Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseasesMarta Pajares, Antonio Cuadrado, Ana I Rojo
Journal of Neurochemistry|June 30, 2009
The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotectionSandra Espada, Ana I Rojo, Marta Salinas, et al.
Journal of Neurochemistry|November 17, 2007
GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stressAna I Rojo, María Rosa de Sagarra, Antonio Cuadrado
Experimental Neurology|September 21, 2007
Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or ratsAna I Rojo, Carmen Cavada, María Rosa de Sagarra, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 20, 2004
Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaBAna I Rojo, Marta Salinas, Daniel Martín, et al.
Cells|July 18, 2020
Inflammation in Parkinson's Disease: Mechanisms and Therapeutic ImplicationsMarta Pajares, Ana I Rojo, Gina Manda, et al.
The Biochemical Journal|February 13, 2003
Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3Mar Pérez, Ana I Rojo, Francisco Wandosell, et al.
Frontiers in Pharmacology|March 19, 2020
Nordihydroguaiaretic Acid: From Herbal Medicine to Clinical Development for Cancer and Chronic DiseasesGina Manda, Ana I Rojo, Elena Martínez-Klimova, et al.
The Journal of Biological Chemistry|March 23, 2006
Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2María Salazar, Ana I Rojo, Diego Velasco, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Current Pharmaceutical Design|February 22, 2008
Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infectionsAntonio Cuadrado, Ana I Rojo
Redox Biology|January 21, 2017
Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseasesMarta Pajares, Antonio Cuadrado, Ana I Rojo
Journal of Neurochemistry|June 30, 2009
The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotectionSandra Espada, Ana I Rojo, Marta Salinas, et al.
Journal of Neurochemistry|November 17, 2007
GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stressAna I Rojo, María Rosa de Sagarra, Antonio Cuadrado
Experimental Neurology|September 21, 2007
Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or ratsAna I Rojo, Carmen Cavada, María Rosa de Sagarra, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 20, 2004
Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaBAna I Rojo, Marta Salinas, Daniel Martín, et al.
Cells|July 18, 2020
Inflammation in Parkinson's Disease: Mechanisms and Therapeutic ImplicationsMarta Pajares, Ana I Rojo, Gina Manda, et al.
The Biochemical Journal|February 13, 2003
Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3Mar Pérez, Ana I Rojo, Francisco Wandosell, et al.
Frontiers in Pharmacology|March 19, 2020
Nordihydroguaiaretic Acid: From Herbal Medicine to Clinical Development for Cancer and Chronic DiseasesGina Manda, Ana I Rojo, Elena Martínez-Klimova, et al.
The Journal of Biological Chemistry|March 23, 2006
Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2María Salazar, Ana I Rojo, Diego Velasco, et al.
Pageof 7